☆ 4.7 Article

Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis

FRONTIERS IN PHARMACOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness

Russell R. Kempker et al.

Summary: This study fills a critical knowledge gap regarding the ability of antituberculosis drugs to penetrate into the cerebrospinal fluid (CSF) and provides valuable pharmacokinetic data for the treatment of tuberculosis meningitis (TBM). Linezolid and cycloserine showed moderate to high CSF penetration and may be effective drugs for TBM treatment, while the efficacy of bedaquiline, delamanid, and clofazimine remains uncertain due to their low CSF penetration.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Clinical Neurology

Tuberculous meningitis: progress and remaining questions

Julie Huynh et al.

Summary: New technologies offer potential for improving the diagnosis and treatment of tuberculous meningitis, while large-scale clinical trials are underway to optimize its management.

LANCET NEUROLOGY (2022)

添加到收藏夹

Review Respiratory System

Extrapulmonary tuberculosis

Surendra K. Sharma et al.

Summary: Tuberculosis is a major global health concern, with extrapulmonary TB accounting for a significant portion of cases. New imaging technologies have improved diagnosis and treatment evaluation, while advances in drug-susceptibility testing have enhanced treatment options for drug-resistant strains. Surgical intervention and adjunctive therapy may also be necessary in certain cases to improve outcomes and manage complications in EPTB patients.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Meropenem Stability in Human Plasma at-20 °C: Detailed Assessment of Degradation

Matthias Gijsen et al.

Summary: The study investigated the degradation of meropenem in human plasma stored at -20 degrees C over 1 year, showing concentration-dependent degradation up to 35.1 mg/L. The findings suggest that meropenem is stable in human plasma at -20 degrees C for at least up to approximately 80 days, with accurate prediction models for degradation provided.

ANTIBIOTICS-BASEL (2021)

添加到收藏夹

Article Infectious Diseases

Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens

A. G. C. Smith et al.

Summary: Intensified multidrug treatment regimens, including the use of fluoroquinolones and injectable agents, in TBM patients resulted in low mortality rates and favorable neurological outcomes, especially when newly implemented drugs were used in patients with multidrug-resistant TBM.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)

添加到收藏夹

Article Infectious Diseases

Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levels

Arthur Hosmann et al.

Summary: This study compared the concentration of meropenem in the blood, cerebrospinal fluid, and cerebral microdialysate of neurointensive care patients. The results showed that the activity concentration of meropenem in brain tissue was significantly higher than in CSF, indicating that CSF concentrations underestimated the activity of meropenem beyond the blood-brain barrier.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

添加到收藏夹

Review Infectious Diseases

Comparative review of imipenem/cilastatin versus meropenem

A. Salmon-Rousseau et al.

MEDECINE ET MALADIES INFECTIEUSES (2020)

添加到收藏夹

Review Immunology

Preclinical models to optimize treatment of tuberculous meningitis - A systematic review

Carlijn H. C. Litjens et al.

TUBERCULOSIS (2020)

添加到收藏夹

Letter Respiratory System

Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients

Samiksha Ghimire et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

添加到收藏夹

Article Cell Biology

Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis

Elizabeth W. Tucker et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

添加到收藏夹

Review Clinical Neurology

Tuberculous meningitis

Robert J. Wilkinson et al.

NATURE REVIEWS NEUROLOGY (2017)

添加到收藏夹

Article Critical Care Medicine

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

Keertan Dheda et al.

LANCET RESPIRATORY MEDICINE (2017)

添加到收藏夹

Article Infectious Diseases

Carbapenems against Mycobacterium tuberculosis: a review of the evidence

D. Jaganath et al.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)

添加到收藏夹

Article Medicine, General & Internal

Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis

A. Dorothee Heemskerk et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Immunology

Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study

J. Kalita et al.

TUBERCULOSIS (2016)

添加到收藏夹

Article Microbiology

Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus

Amit Kaushik et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

添加到收藏夹

Article Pharmacology & Pharmacy

Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update

Abdullah Alsultan et al.

DRUGS (2014)

添加到收藏夹

Article Pharmacology & Pharmacy

Utility of CSF in translational neuroscience

Elizabeth C. M. de Lange

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2013)

添加到收藏夹

Review Clinical Neurology

Tuberculous meningitis: more questions, still too few answers

Guy E. Thwaites et al.

LANCET NEUROLOGY (2013)

添加到收藏夹

Article Microbiology

Activity of Carbapenems Combined with Clavulanate against Murine Tuberculosis

Nicolas Veziris et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

添加到收藏夹

Article Multidisciplinary Sciences

Long-Term Mortality in Patients with Tuberculous Meningitis: A Danish Nationwide Cohort Study

Anne-Sophie Halkjaer Christensen et al.

PLOS ONE (2011)

添加到收藏夹

Review Microbiology

Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

Roland Nau et al.

CLINICAL MICROBIOLOGY REVIEWS (2010)

添加到收藏夹

Article Infectious Diseases

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

K. A. Angeby et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)

添加到收藏夹

Review Immunology

Cerebrospinal fluid concentrations of antituberculosis agents in adults and children

P. R. Donald

TUBERCULOSIS (2010)

添加到收藏夹

Article Immunology

The Newer Fluoroquinolones

Maureen K. Bolan

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)

添加到收藏夹

Article Immunology

Pharmacokinetics and Pharmacodynamics of Antibacterial Agents

Matthew E. Levison et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)

添加到收藏夹

Article Multidisciplinary Sciences

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

Jean-Emmanuel Hugonnet et al.

SCIENCE (2009)

添加到收藏夹

Article Pharmacology & Pharmacy

Safety concerns with Fluoroquinolones

Allana J. Mehhorn et al.

ANNALS OF PHARMACOTHERAPY (2007)

添加到收藏夹

Article Immunology

Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis

H. M. J. Nijland et al.

CLINICAL INFECTIOUS DISEASES (2007)

添加到收藏夹

Review Pharmacology & Pharmacy

Comparative review of the carbapenems

George G. Zhanel et al.

DRUGS (2007)

添加到收藏夹

Review Immunology

Antimicrobial safety: Focus on fluoroquinolones

RC Owens et al.

CLINICAL INFECTIOUS DISEASES (2005)

添加到收藏夹

Article Microbiology

[18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans

M Brunner et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)

添加到收藏夹

Article Microbiology

Comparative stability studies of antipseudomonal β-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)

E Viaene et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)

添加到收藏夹

Article Pharmacology & Pharmacy

The role of fluoroquinolones in tuberculosis today

SE Berning

DRUGS (2001)

添加到收藏夹

Review Pharmacology & Pharmacy

Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters

KE Pickerill et al.

PHARMACOTHERAPY (2000)

添加到收藏夹

Article Clinical Neurology

Mycobacterium tuberculosis meningitis and other etiologies of the aseptic meningitis syndrome

KL Roos

SEMINARS IN NEUROLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.